NB. This article is not published yet. Please try again later.
19 Jan 2017, Webinar, Washington, DC, United States
While the digital health industry promises a revolution in personalized healthcare by bringing together innovative software for healthcare data and cutting-edge life sciences advances, developing a meaningful patent portfolio around those innovations remains a challenge. Recent developments in the courts and at the USPTO have increased the difficulty of protecting those innovations, particularly where the underlying software or technology may build on abstract ideas or laws of nature.
24 Jan 2017, Speaking Engagement, Washington, DC, United States
The first webinar, gMaking the Biosimilar Business CaseExploring the Interface Between Economics and Patent Lawh will explore both the economic market factors of the biosimilar world and patent strategies, and how they impact target selection for biologics and biosimilars.
24 Jan 2017, Webinar, Washington, DC, United States
This first webcast of our series will explore both the economic market factors of the biosimilar world and patent strategies, and how they impact target selection for biologics and biosimilars. In contrast to the development of generic small molecules, it has been reported that it takes seven to eight years to develop a biosimilar at a cost of between $100 million and $250 million.
More Popular Related Articles on Intellectual Property from USA
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
In June 2016, the NHL announced that Las Vegas would be awarded an NHL franchise team, the first major professional sports team in the city and the first new expansion team for the NHL in over fifteen years.
Kirkpatrick Law PC
When clients ask about filing a trademark application or anything else for that matter, it seems like they are only considering the process itself rather than trademark law.
A recent case in the Southern District of Florida serves as a reminder that even trade secrets may be subject to production to opposing counsel.
On December 6, 2016, the parties to the complex and soon-to-be departed world of patent interferences orally argued their positions on motions in what has been described as the "biotech trial of the century"...
All rights to the copyrights in these valuable songs are vested with the music publisher.
Seyfarth Shaw LLP
After a new judge received the case, the new court found the claims patent-eligible and, as an early Christmas gift to the patentee, reversed the prior invalidity finding.
Butler Snow LLP
As a wise trademark owner, you are always watching. Watching for "problem" trademarks that would harm your brand. And one thing you may be watching closely is the U.S. Patent and Trademark Office...
Lewis Roca Rothgerber Christie LLP
Opposer, Fruit of the Loom, Inc., owns numerous trademark registrations for its FRUIT OF THE LOOM trademark for clothing, and specifically for underwear.